智通财经APP讯，透景生命(300642.SZ)发布公告，公司的全资子公司江西透景生命科技有限公司于近日取得江西省药品监督管理局颁发的2项医疗器械注册证，产品名称：纤维蛋白(原)降解产物测定试剂盒(化学发光免疫分析法)、纤溶酶-α2纤溶酶抑制剂复合物测定试剂盒(化学发光免疫分析法)。
上述医疗器械注册证的取得，丰富了公司及江西透景在化学发光产品线的布局，更好满足终端用户对血栓检测项目的临床诊断需求，将进一步增强公司及子公司体外诊断领域的综合竞争力，有利于进一步提高市场拓展能力，对公司未来的生产经营将产生正面影响。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.